CD34 and disease arising from reactivation of latent virus: To assess whether loss of genomes could explain the reactivation defect observed with either of the recombinant viruses containing ICL3 mutations, we quantified viral genome copies from infected hESC-derived CD34+ HPCs at the beginning and end of latent infection via quantitative PCR.